While plenty of people rave about the weight loss results you can get from drugs like Ozempic, there’s also been a ton of chatter over the fact that these meds are really expensive. These drugs ...

The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...

Novo Nordisk, the maker of Ozempic, reported that compounded versions ... The FDA is evaluating supply and demand and monitoring for patient safety. Semaglutide is a medication that mimics the ...

But the evidence looks only at its effect on overweight or obese people, so we don’t yet know its total impact.Wheate points ...

When contacted by Fox News Digital, Ozempic maker Novo Nordisk issued the following statement. "Novo Nordisk welcomes independent research investigating the safety, efficacy and clinical utility ...

The weight loss medication Ozempic has become the most talked-about drug in Hollywood, with several celebrities like Kyle Richards and Garcelle Beauvais denying that they’ve taken it to shed pounds.

Ozempic (semaglutide) helps people with type 2 diabetes lower their blood sugar if diet, exercise, and other diabetes medications haven’t worked. If you’ve just gotten a prescription for it ...

The sky continues to be the limit for semaglutide, the active ingredient in popular drugs Ozempic and Wegovy ... determine the long-term efficacy and safety of GIP/GLP-1 RA medications in diverse ...

A spokesperson for Novo Nordisk, the maker of Ozempic and Wegovy, told The Post it “welcomes independent research investigating the safety, efficacy, and clinical utility of our products.” ...

Ozempic (semaglutide) and Victoza (liraglutide) are prescription drugs used to treat type 2 diabetes and reduce the risk of cardiovascular problems. Both drugs come as an injection. Ozempic and ...

Ozempic (semaglutide) and Wegovy (semaglutide) are prescription drugs that may be used to help with long-term weight loss. But only Wegovy is FDA-approved for this use. Both drugs are approved for ...

Ozempic and Wegovy may not have been developed if not for the insistence of Novo Nordisk's head of research, Mads Krogsgaard. Leadership at the Danish company in the early 1990s were skeptical ...